Oxxon Therapeutics' Acquisition

Oxxon Therapeutics was acquired by Oxford BioMedica on March 12, 2007.

Oxxon Therapeutics is a mid-stage biotechnology company developing a portfolio of immunotherapeutics for infectious disease and cancer in man using its proprietary Heterologous PrimeBoost approach. Th…

Articles about Oxxon Therapeutics' Acquisition: